News on Dyskinesia_Drug_Induced from BioPortfolio.com http://www.BioPortfolio.com Consolidated Dyskinesia_Drug_Induced news from BioPortfolio.com Wed, 10 Feb 2010 03:00:23 GMT en Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034857&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034857&THISHREF=http://c.moreover.com/click/here.pl%3fz2536015272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034857&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034857&THISHREF=http://c.moreover.com/click/here.pl%3fz2536015272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinsons diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034593&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034593&THISHREF=http://c.moreover.com/click/here.pl%3fz2535872978%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034593&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034593&THISHREF=http://c.moreover.com/click/here.pl%3fz2535872978%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029186&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029186&THISHREF=http://c.moreover.com/click/here.pl%3fz2533024999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029186&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029186&THISHREF=http://c.moreover.com/click/here.pl%3fz2533024999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029172&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029172&THISHREF=http://c.moreover.com/click/here.pl%3fz2533016963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029172&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029172&THISHREF=http://c.moreover.com/click/here.pl%3fz2533016963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028974&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028974&THISHREF=http://c.moreover.com/click/here.pl%3fz2532936970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028974&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028974&THISHREF=http://c.moreover.com/click/here.pl%3fz2532936970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028914&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028914&THISHREF=http://c.moreover.com/click/here.pl%3fz2532900325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028914&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028914&THISHREF=http://c.moreover.com/click/here.pl%3fz2532900325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Dyskinesia: Researchers at Boehringer Ingelheim GmbH target dyskinesiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024775&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024775&THISHREF=http://c.moreover.com/click/here.pl%3fz2529159757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024775&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024775&THISHREF=http://c.moreover.com/click/here.pl%3fz2529159757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Research aims to halt disease progressionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019034&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019034&THISHREF=http://c.moreover.com/click/here.pl%3fz2526077689%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019034&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019034&THISHREF=http://c.moreover.com/click/here.pl%3fz2526077689%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIrish Medical Times: eNO Measurement in Pediatric Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994750&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994750&THISHREF=http://c.moreover.com/click/here.pl%3fz2515244846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994750&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994750&THISHREF=http://c.moreover.com/click/here.pl%3fz2515244846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAdvance for Respiratory Care & Sleep Medicine: NMDA antagonist memantine improves levodopa-induced dyskinesias and "On-off" phenomena in Parkinson's diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999111&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999111&THISHREF=http://c.moreover.com/click/here.pl%3fz2517324923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999111&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999111&THISHREF=http://c.moreover.com/click/here.pl%3fz2517324923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMovement Disorders: Current concepts in the management of Parkinson diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988726&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988726&THISHREF=http://c.moreover.com/click/here.pl%3fz2511434778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988726&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988726&THISHREF=http://c.moreover.com/click/here.pl%3fz2511434778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical Journal of Australia: 'Deep Brain Stimulation' For Parkinson's Disease: Study By Scott & White Healthcare Researchershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976716&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976716&THISHREF=http://c.moreover.com/click/here.pl%3fz2504471293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976716&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976716&THISHREF=http://c.moreover.com/click/here.pl%3fz2504471293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Scott & White conducts DBS research for Parkinson's patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967780&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967780&THISHREF=http://c.moreover.com/click/here.pl%3fz2499920021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967780&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967780&THISHREF=http://c.moreover.com/click/here.pl%3fz2499920021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Researchers studying deep brain stimulation for Parkinson's diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966457&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966457&THISHREF=http://c.moreover.com/click/here.pl%3fz2499028927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966457&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966457&THISHREF=http://c.moreover.com/click/here.pl%3fz2499028927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comScience Daily: Scott & White Healthcare researchers studying 'deep brain stimulation' for Parkinson's diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966118&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966118&THISHREF=http://c.moreover.com/click/here.pl%3fz2498883548%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966118&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyskinesia_Drug_Induced&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966118&THISHREF=http://c.moreover.com/click/here.pl%3fz2498883548%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: